Mild cognitive impairment (MCI) is the early stage of cognitive impairment between the
expected cognitive decline of normal aging and the more serious decline of dementia. This …

Objectives The association between gout and dementia, Alzheimer's disease (AD), or
vascular dementia (VD) is not fully understood. The aim of this meta-analysis was to …

Adipokines dysregulation, the main reason for cognitive impairments (CI) induced by
diabetes, shows a sex-dependent pattern inherently and in response to exercise. This study …

Probiotic supplements were shown to improve cognitive function in Alzheimer's disease
(AD) patients. However, it is still unclear whether this applies to older individuals with mild …

Background and purpose Executive function impairment, a slight but noticeable cognitive
deficit in mild cognitive impairment (MCI) patients, is influenced by gamma-aminobutyric …

Little is known about the effect of air pollution on Alzheimer's disease (AD)-specific brain
structural pathologies. There is also a lack of evidence on whether this effect leads to poorer …

Background Alzheimer's disease (AD) is a neurodegenerative condition for which there is
currently no available medication that can stop its progression. Previous studies suggest that …

Background: Mild cognitive impairment (MCI) negatively impacts cognition and dual-task
abilities. A physical–cognitive integrated treatment approach could mitigate this risk for …

Alzheimer's disease (AD) is a critical health issue worldwide that has a negative impact on
patients' quality of life, as well as on caregivers, society, and the environment. Positron …

Many studies suggest a significant association between individual essential trace elements
(ETEs) and cognitive impairment in older adults, but evidence of the synchronized effect of …